Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations.

Authors :: Bongiovanni M
Thoueille P
Barda B
Mercier T
Marzolini C
Ramponi N
Choong E
Cantù M
Decosterd LA
Bernasconi E
Source :: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2024 Jul; Vol. 43 (7), pp. 1503-1504. Date of Electronic Publication: 2024 May 14.
Publication Year :: 2024

Subjects :: Humans
Male
Female
Middle Aged
Recurrence
Aged
Drug Monitoring
Microbial Sensitivity Tests
Adult
Osteomyelitis drug therapy
Osteomyelitis microbiology
Vancomycin analogs & derivatives
Methicillin-Resistant Staphylococcus aureus drug effects
Methicillin-Resistant Staphylococcus aureus isolation & purification
Lipoglycopeptides therapeutic use
Anti-Bacterial Agents therapeutic use
Staphylococcal Infections drug therapy
Staphylococcal Infections microbiology

Language :: English
ISSN :: 1435-4373
Volume :: 43
Issue :: 7
Database :: MEDLINE
Journal :: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Publication Type :: Editorial & Opinion
Accession number :: 38740656
Full Text :: https://doi.org/10.1007/s10096-024-04844-5

Full Text Access

Tools